Several major professional organizations have released a joint statement on the prevention of central line-associated bloodstream infections in acute-care hospitals.
The FDA has approved the first therapy specifically indicated (in combination with plasma exchange and immunosuppressive therapy) for the treatment of adults with acquired thrombotic thrombocytopenic...
The authors of a new study investigated the impact of various complications—such as gastrointestinal bleeding, intracranial hemorrhage, and septicemia—on hospital length-of-stay and mortality risk among...
The authors of a new study investigated the impact of various complications—such as gastrointestinal bleeding, intracranial hemorrhage, and septicemia—on hospital length-of-stay and mortality risk among...
Findings from the ITP World Impact Survey shed light on the most commonly reported symptoms and their severity among patients with ITP, as well as physicians’ perceptions of the frequency and severity of...
Findings from the ITP World Impact Survey shed light on the most commonly reported symptoms and their severity among patients with ITP, as well as physicians’ perceptions of the frequency and severity of...
Researchers may have uncovered an array of biomarkers associated with outcomes in immune-mediated thrombotic thrombocytopenic purpura. Until now, reliable biomarkers predictive of outcomes in this patient...
Researchers may have uncovered an array of biomarkers associated with outcomes in immune-mediated thrombotic thrombocytopenic purpura. Until now, reliable biomarkers predictive of outcomes in this patient...
